Published in J Pediatr on January 01, 1993
Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev (1997) 4.32
Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev (2010) 3.58
Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun (1996) 3.53
Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ (2001) 3.10
Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10. Infect Immun (1995) 2.91
Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis. Clin Microbiol Rev (2008) 2.57
Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect Immun (2000) 2.19
Endothelial cell GlcNAc beta 1-4GlcNAc epitopes for outer membrane protein A enhance traversal of Escherichia coli across the blood-brain barrier. Infect Immun (1996) 2.02
Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like beta-lactamase genes. Antimicrob Agents Chemother (1997) 1.84
The plasmid of Escherichia coli strain S88 (O45:K1:H7) that causes neonatal meningitis is closely related to avian pathogenic E. coli plasmids and is associated with high-level bacteremia in a neonatal rat meningitis model. Infect Immun (2009) 1.53
Identification of Escherichia coli outer membrane protein A receptor on human brain microvascular endothelial cells. Infect Immun (2002) 1.53
The gene locus yijP contributes to Escherichia coli K1 invasion of brain microvascular endothelial cells. Infect Immun (1999) 1.24
The capsule supports survival but not traversal of Escherichia coli K1 across the blood-brain barrier. Infect Immun (1999) 1.21
Etiologies of autism in a case-series from Tanzania. J Autism Dev Disord (2006) 1.19
Neonatal meningitis. Arch Dis Child Fetal Neonatal Ed (2003) 1.18
Identification and characterization of a novel Ibe10 binding protein that contributes to Escherichia coli invasion of brain microvascular endothelial cells. Infect Immun (1999) 1.15
Escherichia coli binding to and invasion of brain microvascular endothelial cells derived from humans and rats of different ages. Infect Immun (1999) 1.14
The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis. Infect Immun (2004) 1.12
Use of diagnostic microarrays for determination of virulence gene patterns of Escherichia coli K1, a major cause of neonatal meningitis. J Clin Microbiol (2005) 1.10
Identification of Escherichia coli genes that are specifically expressed in a murine model of septicemic infection. Infect Immun (2002) 1.02
Identification and characterization of S fimbria-binding sialoglycoproteins on brain microvascular endothelial cells. Infect Immun (1997) 1.01
Choice and duration of antimicrobial therapy for neonatal sepsis and meningitis. Int J Pediatr (2011) 0.99
NlpI contributes to Escherichia coli K1 strain RS218 interaction with human brain microvascular endothelial cells. Infect Immun (2010) 0.93
Isolation of Proteus mirabilis from severe neonatal sepsis and central nervous system infection with extensive pneumocephalus. Eur J Pediatr (2003) 0.92
The NeuC protein of Escherichia coli K1 is a UDP N-acetylglucosamine 2-epimerase. J Bacteriol (2004) 0.92
Novel model to study virulence determinants of Escherichia coli K1. Infect Immun (2007) 0.90
The microbial spectrum of neonatal sepsis in Uganda: recovery of culturable bacteria in mother-infant pairs. PLoS One (2013) 0.85
Cytotoxic necrotizing factor 1 contributes to Escherichia coli meningitis. Toxins (Basel) (2013) 0.82
Attenuation of biopterin synthesis prevents Escherichia coli K1 invasion of brain endothelial cells and the development of meningitis in newborn mice. J Infect Dis (2012) 0.82
Neuropathogenic Escherichia coli K1 does not exhibit proteolytic activities to exert its pathogenicity. J Negat Results Biomed (2013) 0.79
Meningitis in the Neonate. Curr Treat Options Neurol (2002) 0.79
Vaginal carriage of enterotoxigenic Bacteroides fragilis in pregnant women. J Clin Microbiol (1997) 0.77
Interactions of neuropathogenic Escherichia coli K1 (RS218) and its derivatives lacking genomic islands with phagocytic Acanthamoeba castellanii and nonphagocytic brain endothelial cells. Biomed Res Int (2014) 0.76
Human Meningitis-Associated Escherichia coli. Ecosal Plus (2016) 0.76
Neonatal meningoventriculitis due to proteus mirabilis - a case report. J Clin Diagn Res (2012) 0.75
Comparison Between Pathogen Associated Laboratory and Clinical Parameters in Early-Onset Sepsis of the Newborn. Open Microbiol J (2016) 0.75
Amplitude-integrated electroencephalography and MRI findings in a case of severe neonatal methicillin-resistant Staphylococcus aureus meningitis. BMJ Case Rep (2010) 0.75
Concurrent neonatal Proteus mirabilis infection in dizygotic twins. Can J Infect Dis (1999) 0.75
Impact of round-the-clock CSF Gram stain on empirical therapy for suspected central nervous system infections. Eur J Clin Microbiol Infect Dis (2015) 0.75
Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med (1974) 7.89
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med (1994) 6.92
Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet (1975) 6.25
Antimicrobial susceptibility of Hemophilus influenzae. Pediatrics (1970) 4.51
Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med (1988) 4.17
The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med (1991) 3.94
Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med (1993) 3.67
Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J (1993) 3.38
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. J Infect Dis (1981) 3.28
Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun (1982) 3.18
A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. J Pediatr (1976) 3.13
Distribution and significance of fecal indicator organisms in the Upper Chesapeake Bay. Appl Microbiol (1975) 2.99
Group B streptococci: the new challenge in neonatal infections. J Pediatr (1973) 2.90
A minor high-molecular-weight outer membrane protein of Haemophilus influenzae type b is a protective antigen. Infect Immun (1985) 2.81
Editorial: Should ampicillin be abandoned for treatment of Haemophilus influenzae disease? JAMA (1974) 2.79
The spectrum of group B streptococcal infections in infancy. Am J Dis Child (1974) 2.72
Screening for cephalosporin-resistant Streptococcus pneumoniae with the Kirby-Bauer disk susceptibility test. J Clin Microbiol (1993) 2.69
Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet (1974) 2.67
Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics (1986) 2.62
Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother (1993) 2.61
Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1995) 2.50
Tumor necrosis factor alpha/cachectin and interleukin 1 beta initiate meningeal inflammation. J Exp Med (1990) 2.33
Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis. Antimicrob Agents Chemother (1980) 2.27
Sepsis neonatorum. N Engl J Med (1981) 2.27
Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr (1976) 2.26
Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics (1989) 2.23
In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins. Antimicrob Agents Chemother (1980) 2.21
Use of polymerase chain reaction and rabbit infectivity testing to detect Treponema pallidum in amniotic fluid, fetal and neonatal sera, and cerebrospinal fluid. J Clin Microbiol (1991) 2.20
Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr (1989) 2.17
Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy. Report of the Second Neonatal Meningitis Cooperative Study Group. Lancet (1980) 2.15
A pharmacologic evaluation of penicillin in children with purulent meningitis. N Engl J Med (1977) 2.14
The rate of bacteriologic response to antimicrobial therapy in neonatal meningitis. Am J Dis Child (1972) 2.13
The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J Bacteriol (2000) 2.10
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis. Antimicrob Agents Chemother (1982) 2.08
Conservation of epitopes in the oligosaccharide portion of the lipooligosaccharide of Haemophilus influenzae type b. Infect Immun (1987) 2.06
Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr (1993) 2.05
Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect Immun (1998) 2.03
Cellulose acetate impressions of the ocular surface. Dry eye states. Arch Ophthalmol (1983) 2.03
Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr (1990) 2.01
Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr (1981) 2.00
Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis (1984) 1.98
Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother (1994) 1.96
A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr Res (1976) 1.96
A protective epitope of Moraxella catarrhalis is encoded by two different genes. Infect Immun (1997) 1.89
A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun (1993) 1.84
Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J Bacteriol (1999) 1.82
Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J (1999) 1.81
Incidence of Salmonella spp., Clostridium botulinum, and Vibrio parahaemolyticus in an estuary. Appl Environ Microbiol (1976) 1.80
Adverse fetal outcome following maternal rubella after the first trimester of pregnancy. JAMA (1969) 1.78
Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. A controlled trial in 18,738 newborn infants. N Engl J Med (1980) 1.78
Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet (1983) 1.77
Clinical pharmacology and efficacy of vancomycin in pediatric patients. J Pediatr (1980) 1.71
Leukocyte function and the development of opsonic and complement activity in the neonate. Am J Dis Child (1971) 1.68
Pharmacological basis for antimicrobial therapy in newborn infants. Am J Dis Child (1974) 1.66
Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis (1989) 1.66
Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. Pediatrics (1980) 1.66
Comparative pharmacokinetics of amoxicillin and ampicillin in infants and children. Pediatrics (1979) 1.65
A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J Infect Dis (1993) 1.63
A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J Infect Dis (1994) 1.62
Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J (1992) 1.61
Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis. Antimicrob Agents Chemother (1982) 1.61
Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol (1984) 1.60
Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae. Infect Immun (1987) 1.59
Gentamicin in the neonatal period. Am J Dis Child (1970) 1.59
Biodegradation of phenylmercuric acetate by mercury-resistant bacteria. Appl Microbiol (1973) 1.58
Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo. J Pediatr (1967) 1.57
Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr (1989) 1.56
Trimethoprim-sulfamethoxazole therapy for shigellosis. JAMA (1976) 1.56
The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child (1978) 1.54
Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. J Infect Dis (1985) 1.54
Congenital cytomegalic inclusion disease. A longitudinal study of 20 patients. Am J Dis Child (1969) 1.54
Etiology and medical management of acute suppurative bone and joint infections in pediatric patients. J Pediatr Orthop (1982) 1.54
Urinary tract infections in young infants. Pediatrics (1982) 1.54
Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J (1990) 1.53
Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis (1998) 1.52
The changing epidemiology of bacteremia in neutropenic children with cancer. Pediatr Infect Dis J (1995) 1.52
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types. Pediatr Infect Dis J (1997) 1.52
Changing pattern of the antimicrobial susceptibilities of Escherichia coli in neonatal infections. J Pediatr (1971) 1.51
Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. J Antimicrob Chemother (1994) 1.51
Infections in children caused by the HB group of bacteria. J Pediatr (1973) 1.49
In vitro susceptibilities of common pediatric pathogens to LY163892. Antimicrob Agents Chemother (1988) 1.49
Tumor necrosis factor in mediating experimental Haemophilus influenzae type B meningitis. J Clin Invest (1989) 1.48
Purulent pericarditis in infancy. Pediatrics (1967) 1.48
Immunoglobulin concentrations in newborn infants with congenital cytomegalic inclusion disease. Pediatrics (1965) 1.47
Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis. Antimicrob Agents Chemother (1983) 1.47
Cefprozil concentrations in middle ear fluid of children with acute otitis media. Pediatr Infect Dis J (2000) 1.47
Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child (1989) 1.46
Osteomyelitis in infants and children. A review of 163 cases. Am J Dis Child (1975) 1.46
Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr (1979) 1.46
Streptococcal submandibular cellulitis in young infants. Pediatrics (1981) 1.45